Anti-Cripto1/CRIPTO antibody [EPNCIR106A]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal Cripto1/CRIPTO antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 6 publications.
View Alternative Names
CRIPTO-1, TDGF1, CRIPTO, Protein Cripto, Cripto-1 growth factor, Epidermal growth factor-like cripto protein CR1, Teratocarcinoma-derived growth factor 1, CRGF
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Cripto1/CRIPTO antibody [EPNCIR106A] (AB108391)
Intracellular Flow Cytometry analysis of NCCIT (human pluripotent embryonal carcinoma) cells labeling Cripto1/CRIPTO with purified ab108391at 1/2200 dilution (1ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cripto1/CRIPTO antibody [EPNCIR106A] (AB108391)
Immunocytochemistry/ Immunofluorescence analysis of NCCIT (Human pluripotent embryonic carcinoma epithelial cell) cells labeling Cripto1/CRIPTO with Purified ab108391 at 1 : 500 dilution (1.1μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IP
Lab
Immunoprecipitation - Anti-Cripto1/CRIPTO antibody [EPNCIR106A] (AB108391)
ab108391 (purified) at 1 : 30 dilution (2ug) immunoprecipitating Cripto1/CRIPTO in NCCIT (Human pluripotent embryonic carcinoma epithelial cell) whole cell lysate.
Lane 1 (input) : NCCIT (Human pluripotent embryonic carcinoma epithelial cell) whole cell lysate 10ug
Lane 2 (+) : ab108391 & NCCIT (Human pluripotent embryonic carcinoma epithelial cell) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab108391 in NCCIT (Human pluripotent embryonic carcinoma epithelial cell) whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
All lanes:
Immunoprecipitation - Anti-Cripto1/CRIPTO antibody [EPNCIR106A] (ab108391)
Predicted band size: 21 kDa
false
- WB
Lab
Western blot - Anti-Cripto1/CRIPTO antibody [EPNCIR106A] (AB108391)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Cripto1/CRIPTO antibody [EPNCIR106A] (ab108391) at 1/2000 dilution
All lanes:
NCCIT (Human pluripotent embryonic carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/2000 dilution
Predicted band size: 21 kDa
false
- WB
Unknown
Western blot - Anti-Cripto1/CRIPTO antibody [EPNCIR106A] (AB108391)
All lanes:
Western blot - Anti-Cripto1/CRIPTO antibody [EPNCIR106A] (ab108391) at 1/1000 dilution
All lanes:
NCCIT cell lysate at 10 µg
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
Related conjugates and formulations (1)
-
578 PE
PE Anti-Cripto1/CRIPTO antibody [EPNCIR106A]
Reactivity data
Product details
This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of David Solomon. View antibodies from NCI Center for Cancer Research Collaboration.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in genetics 13:819682 PubMed35222539
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:730615 PubMed34434900
2021
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:485 PubMed33850882
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 121:545-556 PubMed31310365
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 25:1426-1441 PubMed29445127
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 292:4138-4151 PubMed28126904
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com